Research Reports
Research Reports
Free News and Due Diligence Software
New Diligence, free News and Due Diligence software is now available. Use the software to improve your research and due diligence efforts. Learn more.
New Diligence Software
New Diligence is free software. It allows investors to perform news driven due diligence, allowing them to follow a large number of companies with a minimal investment of time.
Generex Biotechnology
Unlike the NNVC plunge with seemed to have no reason to occur, GNBT had “bad news” on October 20th when it released a Going Concern notice as required by Nasdaq regulations. Before we discuss the going concern issue, I would like to visit the reasons I traded GNBT earlier in the year.
Generix has several [...]
CanAlaska Uranium – Part II
In the first article I provided some general background about the company. In this article I will explain why I am a buyer of the stock.
I generally avoid long time horizon investments – there is so much time risk in the market that 95% of my trades are relatively short term. That will [...]
CanAlaska Uranium – Part I
Canalaska, stands out as a well-capitalized, well-managed junior uranium miner. While most American investors have focused their attention on companies like URRE and UEC, this Canadian company has assembled a top-flight management team with superior land holdings that would seem to have far greater long-term potential for significant resource development. Capital raising is [...]
Welcome to Collective Stock
The goal of Collective Stock is to provide brief but useful reports that allow traders and investors to quickly complete some basic due diligence and make an actionable trading or investment decision.